logo
  • 台北
  • 台中
  • 高雄
  • 新加坡
event-banner
event-banner
線下活動科技學習

2026 ATC抗體藥物暨第21屆前瞻生醫新知研討會

766
3
avatar
台灣抗體協會
2026.05.26 (Tue) 08:30 - 05.27 (Wed) 12:00 (GMT+8)加入行事曆
南港區研究院路一段130巷99號C201廳, Taipei City, Taiwan

國家生技研究園區國際會議廳

相關連結

活動官網

線下活動

報名完成後出示 ACCUPASS App 中的票券即可快速入場。

實際入場相關規定以活動主辦方為主。

如何取票?
  • 抗體研討會
  • Antibody
2026 Antibody Therapeutics Conference & 21st Frontiers in Biomedical Sciences Conference 2026 ATC抗體藥物暨第21屆前瞻生醫新知研討會
2026 Antibody Therapeutics Conference & 21st Frontiers in Biomedical Sciences Conference 2026 ATC抗體藥物暨第21屆前瞻生醫新知研討會

線下活動

報名完成後出示 ACCUPASS App 中的票券即可快速入場。

實際入場相關規定以活動主辦方為主。

如何取票?
活動簡介

On behalf of the organizing committee, it is my great pleasure to welcome you to the 13th Antibody Therapeutic Conference (ATC) – the 2026 Antibody Therapeutics Conference: Extended Applications of Antibodies. The conference will be held on May 26–27, 2026, at the National Biotechnology Research Park in Taipei, Taiwan.

In recent years, the field of antibody therapeutics has continued to experience remarkable growth, particularly in the treatment of cancer, immune-mediated diseases, and infectious diseases. Advances in antibody engineering have led to the rapid development of next-generation modalities, including bispecific antibodies, antibody-drug conjugates (ADCs), and T-cell–engaging therapies.

These innovative immunotherapies—ranging from checkpoint blockade and ADCs to chimeric antigen receptor T-cell (CAR-T) therapies—are transforming the landscape of modern medicine and offering new hope for patients with previously difficult-to-treat diseases.

This year, ATC will continue to showcase a broad spectrum of remarkable achievements, with a focus on the extended applications of antibodies and emerging therapeutic modalities for the treatment of human diseases. We aim to provide a platform for participants to connect, communicate, gain new knowledge, and discuss the latest advances in this rapidly evolving field.

The Taiwan Antibody Association (TAA), the organizer of ATC, was established in 2012 with the mission of facilitating research and industrial development of antibody therapeutics and related technologies in Taiwan. By hosting international conferences such as ATC, we hope to promote the exchange of ideas and foster collaborations between senior experts and young scientists from around the world.

We sincerely hope that this conference will be informative and inspiring, and that it will encourage meaningful contributions to the advancement of antibody therapeutics. Once again, we thank you for joining us and wish you a productive and enjoyable conference.


Han-Chung Wu
Chairman, Taiwan Antibody Association
Distinguished Research Fellow, Institute of Cellular and Organismic Biology, Academia Sinica Fellow, National Academy of Inventors (NAI)

 

Visit Official Website for more details: https://antibody.org.tw/atc2026/index.php

 

 

 

 

 



 

主辦
喜歡
立即報名
avatar

台灣抗體協會

2026 ATC抗體藥物暨第21屆前瞻生醫新知研討會

2026.05.26 (Tue) 08:30 - 05.27 (Wed) 12:00 (GMT+8)

立即報名

活動嘉賓

Man-Cheong Fung
Man-Cheong Fung
Ken J. Ishii 石井健
Ken J. Ishii 石井健
Shie-Liang Hsieh 謝世良
Shie-Liang Hsieh 謝世良
Alice L. Yu 陳鈴津
Alice L. Yu 陳鈴津
Kai-Chien Yang 楊鎧鍵
Kai-Chien Yang 楊鎧鍵
Divay Bagga
Divay Bagga
Pei-Jiun Chen 陳佩君
Pei-Jiun Chen 陳佩君
Chien-Jen Chen 陳建仁
Chien-Jen Chen 陳建仁
Wen-Hwa Lee 李文華
Wen-Hwa Lee 李文華
Hsing-Jien Kung 龔行健
Hsing-Jien Kung 龔行健
Ming-Che Shih 施明哲
Ming-Che Shih 施明哲
John Yu 游正博
John Yu 游正博
Dah-Tsyr Chang 張大慈
Dah-Tsyr Chang 張大慈
Andrew H.-J. Wang 王惠鈞
Andrew H.-J. Wang 王惠鈞
Sherry, Mann-Ching Ku 顧曼芹
Sherry, Mann-Ching Ku 顧曼芹
Yan-Hwa Wu Lee 吳妍華
Yan-Hwa Wu Lee 吳妍華
Yau-Huei Wei 魏耀揮
Yau-Huei Wei 魏耀揮
活動地圖

南港區研究院路一段130巷99號C201廳, Taipei City, Taiwan

舉辦活動

  • 常見問題
  • 首次舉辦活動
  • 活動上架規範
  • 活動人社群

主辦百寶箱

  • 生活誌
  • 平台基礎服務
  • 線上活動相關
  • 廣告曝光方案
  • ACCUPAI 雲攝影

認識我們

  • 加入我們

客服中心

  • Email: service@accupass.com
  • 週一至週五 10:00-18:30
  • 詢問小幫手

關於我們

facebook
line
blog
youtube

下載 ACCUPASS App

download-google-playdownload-ios

語言

繁體中文
盈科泛利股份有限公司 © Accuvally Inc. All Rights Reserved. 統一編號 Tax ID number 25023938
loading